A new Swiss study found that people who have secondary progressive MS who took the drug rituximab reported less disabling symptoms over a 10-year period than those who didn't. People taking the drug also had a slower progression of MS symptoms.
from WebMD Health https://wb.md/2M3j4uI
via IFTTT
Comments
Post a Comment